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SI Materials and Methods
Yeast Two-Hybrid Assay.The PJ69-4α strain was obtained from the
Yeast Resource Center at the University of Washington. Bag6
fragments A (residues 1–225), B (residues 226–399), C (residues
400–659), D (residues 660–950), E (residues 951–1,126), Bag6EN
(residues 951–1,011), Bag6ENLS (residues 1,012–1,054), and
Bag6EBAG (residues 1,055–1,126) were cloned into the pGAD-C1
vector. TRC35, TRC35-N (residues 1–157), TRC35-C (resi-
dues 158–327), and Ubl4A were cloned into the pGBDU-C1
vector. Alanine mutants were made using site-directed mu-
tagenesis (Agilent Technologies). pGAD-C1 and pGBDU-C1
containing genes of interest were cotransformed into PJ69-4α
using previously described methods (1) and then were plated on
SC-Ura-Leu and incubated at 30 °C. The double transformants
then were inoculated into 5 mL SC-Ura-Leu and grown over-
night in a shaking incubator (Multitron Standard Infors HT) at
200 rpm at 30 °C. From the cultures 2 × 107 cells were re-
inoculated into 5 mL total SC-Ura-Leu and grown in a shaker
incubator for 6 h. Cells were harvested by spinning at 3,000 × g at
room temperature and were washed twice with 5 mL sterile
water. Then 1 × 107 cells were resuspended in 40 μL of sterile
water, and 4 μL of this resuspended sample was spot-plated onto
SC-Ura-Leu-Ade and grown for 72 h at 30 °C.
Cloning, Expression, and Purification.For crystallization, 54 residues
from Bag6 (Q1054–D1107) and the 53 C-terminal residues from
Ubl4A (P93–P145) were coexpressed with pET33b plasmid with
the N-terminal 6xHis tag on Ubl4A-C. To facilitate tobacco etch
virus (TEV) cleavage of the histidine tag, three flexible residues,
glycine, alanine, and serine, were inserted between the TEV cut
site and P93 of Ubl4A using site-directed mutagenesis. The
proteins were expressed in E. coli NiCo21(DE3) (New England
Biolabs) for 3 h at 37 °C after induction with 300 μM isopropyl-
β-D-thiogalactopyranoside (Affymetrix). Cells were lysed using
an S-4000 sonicator (Misonix) in 50 mM NaH2PO4, 200 mM
NaCl, 20 mM imidazole supplemented with benzamidine, PMSF,
and 0.5% Triton X-100. The complex was purified by Ni-NTA
affinity chromatography (Qiagen) and then was incubated over-
night at room temperature with TEV protease in 20 mM NaH2PO4,
100 mM NaCl, 20 mM imidazole, and 10 mM β-mercaptoethanol
followed by size-exclusion chromatography on a Superdex 75 gel-
filtration column in 10 mM Tris, 50 mM NaCl (pH 8.0) and was
concentrated to ∼10 mg/mL.
All truncations of Bag6 were purified using the protocol de-
scribed above. The 53 C-terminal residues from L1055 to D1107
of Bag6 were cloned for Bag6-BAG. The Bag6/Ubl4A construct
contained the 73 C-terminal residues and full-length Ubl4A. The
175 C-terminal residues from V951 to P1126 were cloned in the
Bag6 E fragment vector. Bag6-C81 contained the 81 C-terminal
residues from K1046 to P1126.
cDNA of human Hsc70, Hdj1, and Hsc70-NBD (residues P5 to
S381) were subcloned into pET33b vector, expressed, and puri-
fied as previously described (2), with some modifications. Full-
length Hsc70 and Hsc70-NBD were purified over a UnoQ col-
umn (Bio-Rad) [50 mM Hepes, 50–500 mM KCl gradient (pH
8.0), 5 mM β-mercaptoethanol]. Hdj1 was purified over a UnoS
column [50 mM Hepes, 20–500 mM KCl gradient, 500 mM KCl
(pH 7.0), 5 mM β-mercaptoethanol]. The plasmid vectors con-
taining the cDNA of the chaperone proteins were obtained from
the Morimoto group at Northwestern University, Evanston, IL (3).
cDNA of human TRC40 was subcloned into the pGEX-6P-1
vector and was expressed in NiCo21(DE3) cells. Cells were lysed
using an M-110L Microfluidizer Processor (Microfluidics) in
50 mM NaH2PO4 and 400 mM NaCl supplemented with
benzamidine, PMSF, and 5 mM β-mercaptoethanol. The protein
was purified in single-step glutathione SuperFlow resin affinity
chromatography (Clontech).
cDNA of human SGTA was subcloned into the pET33b vector
and was coexpressed with MBP-Sbh1 in the pACYCDuet vector
in NiCo21(DE3) cells. Cells were lysed using an M-110L
Microfluidizer Processor (Microfluidics) in 50 mM NaH2PO4,
150 mM NaCl, 20 mM imidazole supplemented with benzami-
dine, PMSF, and 5 mM β-mercaptoethanol. The complex was
purified in two steps using Ni-NTA resin (Qiagen) and amylose
resin (New England Biolabs).
Human TRC35(23–305) was subcloned from TRC35 cDNA
into the pACYCDuet vector in the first multiple cloning site (MCS)
with an N-terminal 6xHis tag and a TEV protease cut site. In the
second MCS, cDNA of untagged human Ubl4A was subcloned.
The subcloned TRC35 fragment in pACYCDuet was coexpressed
with untagged Bag6(1,001–1,126) in pET33b in NiCo21(DE3). The
complex was purified by Ni-NTA affinity chromatography
(Qiagen). Contaminants were removed further using chitin af-
finity chromatography (New England Biolabs). TRC40(K86D),
TRC35(D84K), SGTA(C38A), and Ubl4A(L43A) mutants were
generated using site-directed mutagenesis (Agilent Technologies).
Circular Dichroism.Circular dichroism spectra were obtained using
an Aviv 62A DS circular dichroism spectrometer. The ellipticity
of 10 μM of Bag6-BAG, Ubl4A-C, or Bag6/Ubl4A suspended in
10 mM Tris, 50 mM NaCl (pH 8.0) was measured.
Crystallization. Crystallization screening was performed using the
sitting-drop vapor-diffusion method with commercially available
screens (Hampton) and was set up by a Mosquito robot (TTP
Labtech) and incubated at room temperature. The heterodimer
crystallized after 4 d as rectangular prisms in 20% (wt/vol) PEG-3350,
0.05 M Hepes (pH 7.0), 1% tryptone (Hampton). The crystals
were soaked in 20% (vol/vol) glycerol for 15 s and cryopreserved
in liquid nitrogen. Iodide derivatives were generated by soaking
crystals in 40 μL mother liquor [20% (wt/vol) PEG-3350, 0.05 M
Hepes (pH 7.0), 1% tryptone (Hampton)], 10 μL ethylene glycol,
and 3 μL 6 M sodium iodide for 2–10 s before cryopreservation.
Data Collection, Structure Solution, and Refinement. X-ray diffrac-
tion data were collected on Beam Line 8.2.1 at the Advanced
Light Source (ALS) at Lawrence Berkeley National Laboratory.
A complete dataset was collected from a single crystal to 2.0-Å
resolution. Data were integrated, scaled, and merged using
MOSFLM (4) and XDS (5), and the data were merged and
converted with SCALA (6, 7). Phases were determined by single-
wavelength anomalous dispersion data merged from three iodide
derivative crystals, which diffracted to 3.5 Å. The model was
obtained by PHASER (8) and RESOLVE (9) as implemented
automatically by PHENIX (10) and further refined against
the native dataset using COOT (11) for manual building and
PHENIX (10). The final model contained four molecules in the
asymmetric unit with three of the four heterodimers having an
rmsd of 0.382 accounting for residues 97–128 of Ubl4A and
1,058–1,102 of Bag6. The final heterodimer, molecules F and G
(rmsd = 0.675 when included), appeared to have a slightly al-
tered conformation of the second helix in the Ubl4A di-
merization domain that could not be fully resolved; however,
there was no significant change to the overall architecture.
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β-Galactosidase Refolding Assay. The Hsc70-mediated β-galacto-
sidase refolding assay was carried out as previously reported (3)
with modifications. A stock solution of β-galactosidase at
10 mg/mL was prepared by dissolving the enzyme (Sigma-Aldrich)
in 50 mM Tris·HCl, 10 mM MgCl2, 5 mM β-mercaptoethanol
(pH 7.3). For experiments, the stock enzyme was diluted 1:10 in
1 M glycylglycine (pH 7.4); 5 μL of this stock was diluted into
95 μL of unfolding buffer [25 mM Hepes, 5 mM MgCl2, 50 mM
KCl, 5 mM mercaptoethanol, 6 M guanidine-HCl (pH 7.4)], and
5 μL was diluted into 95 μL 1 M glycylglycine (pH 7.4) for the
control. The final β-galactosidase concentration was 3.4 nM. The
two samples were incubated at 30 °C for 30 min.
Folding reactions were performed in refolding buffer [1.6 μM
Hsc70 and 3.2 μM Hdj1 suspended in 25 mM Hepes, 5 mM
MgCl2, 50 mM KCl, 2 mM ATP, 10 mM DTT (pH 7.4)]. Varying
concentrations of Bag6 constructs were tested for their effect on
Hsc70 folding activity. After 30-min incubation at 30 °C, 1 μL of
denatured enzyme was added to 124 μL of each refolding re-
action tube and incubated at 37 °C. At regular time intervals,
10 μL of each folding reaction was added to 10 μL of 0.8 mg/mL
ortho-nitrophenyl-β-galactoside (ONPG) and incubated at 37 °C
for 15 min. The reaction was stopped by the addition of 80 μL
0.5 M sodium carbonate. β-Galactosidase activity was measured
as the rate of conversion of ONPG by absorbance at 413 nm.
Hsp/Hsc70 Capture Assays. Five hundred picomoles of Hsc70-NBD
with an N-terminal 6xHis tag were incubated with 2 nmol of
untagged Bag6-BAG, Bag6-C81, Bag6EBAG/Ubl4A, and Bag1-
BAG in a total of 100 μL of binding buffer (20 mM Hepes, 100
mM KCl, 20 mM imidazole, and 5 mM β-mercaptoethanol) for
1 h at room temperature. The samples then were added to 15 μL
of Ni-NTA beads (Qiagen). The beads were washed twice with
100 μL of binding buffer. Bound proteins were eluted with 15 μL
of 20 mM Hepes, 100 mM KCl, 300 mM imidazole, and 5 mM
β-mercaptoethanol and then were run on a 4–20% gradient
SDS/PAGE gel (Bio-Rad). Four percent of the total sample was
run as loading control.
For capture assays from 293T whole-cell lysate, cells from a
10-cm dish (90%confluent) were lysed in 1.5mLNonidet P-40 lysis
buffer [50 mM Tris·HCl (pH 7.4), 150 mM NaCl, 2 mM MgCl2,
0.5% Nonidet P-40, 2 mM β-mercaptoethanol, protease inhibitor
mixture]. Cell extracts were subject to centrifugation at 20,000 × g
for 5 min to remove insoluble materials. The soluble fractions
were pretreated with 180 mL HisPur Coblat resin (Thermo) and
then were incubated with 30 mL HisPur Coblat resin immobilized
with histidine-tagged Bag6-fragments at 4 °C for 1 h, as indicated
in Fig. 5B. The resins were washed twice quickly with 400 mL of
a wash buffer [50 mM Tris·HCl (pH 7.4), 150 mM NaCl, 2 mM
MgCl2], 0.1% Nonidet P-40, and 2 mM β-mercaptoethanol. The
proteins bound to the resin were eluted with 60 mL SDS/PAGE
loading buffer and denatured by heating at 65 °C for 10 min. The
samples were analyzed by SDS/PAGE. Proteins were detected by
either Ponceau staining and immunoblotting.
To examine the in vivo interaction of Bag6 and Hsp70, cells
grown in a six-well plate were transfected with plasmids
expressing FLAG-tagged wild-type Bag6 or mutant Bag6 lacking
the 81 C-terminal amino acids using TransIT 293 (Mirus). Cells
were lysed in the Nonidet P-40 lysis buffer 24 h post transfection.
Bag6 was pulled down from the lysate by FLAG M2 beads
(Sigma-Aldrich). The precipitated material was analyzed by
immunoblotting.
In Vitro TA Handoff Assay. hSGTA/MBP-Sbh1 (6.25 pmol) or
hSGTA(C38A)/MBP-Sbh1 (6.25 pmol) was incubated with 62.5
GST-TRC40 or GST-TRC(K86D) with or without 0.008 μg/μL of
Bag6min, Bag6min(D84K), or Bag6min(L43A) complex in 100 μL of
incubation buffer [50 mM Hepes (pH 7.5), 4 mM Mg(OAc)2, 150
mMKOAc, 10% glycerol, and 1 mMDTT] on ice for 10 min. After
10 min, 10 μL of MagneGST resin (Promega) was added to each
reaction and incubated at room temperature for 15 min to pull
down GST-TRC40 and bound factors. The resin was washed three
times with 500 μL of incubation buffer and eluted with 20 μL of 20
mM Tris, 300 mM NaCl, and 33 mM L-glutathione (pH 7.4). The
precipitated material was analyzed by immunoblotting. For the
wild-type capture experiment, ∼12 ± 5.2% of TRC40 and 4.1 ±
1.6% of Sbh1 were eluted from the beads. One would expect ∼12%
of the TA to be captured assuming 100% transfer; therefore, our
yield is ∼25%. Differences could be attributed to a variety of factors
such as differences in the affinities of the various TRC40 complexes.
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Fig. S1. Purification of functional recombinant proteins used in the in vitro TA transfer assay. (A) Two-hybrid assay using full-length TRC35 and TRC35(23–305)
with the Bag6E fragment. Both TRC35 constructs display strong two-hybrid interactions. (B) Representative Coomassie-stained 12% SDS/PAGE gel of purified
hSGTA/MBP-Sbh1, Bag6min complex, and GST-TRC40.
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Fig. S2. Individual results for various in vitro refolding assays. β-Galactosidase refolding assays in the presence of Hsc70, Hdj1, and/or other factors as labeled.
Colors are based on Fig. 5 except for assays containing Bag6-C81, which are in cyan. Error bars are from three independent experiments.
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Fig. S3. A comparison of Bag6-BAG and canonical BAG domains. (A) Published structures of BAG domains are shown as ribbons similar to Bag6-BAG. Residues
involved in Hsp/Hsc70 binding are highlighted as magenta sticks. (B) Sequence alignment of human Bag1-BAG, Bag5-BAG5, and Bag6-BAG with the known
secondary structure indicated. (C) In vitro capture by 6xHis-Hsc70-NBD of Bag6-BAG, Bag6-C81, Bag6EBAG/Ubl4A, or Bag1-BAG. Protein was pulled down (PD)
with Ni-NTA after incubation with 6xHis-Hsc70-NBD. Four percent of total loaded protein is shown as a loading control (LC), and each protein was incubated
alone with Ni-NTA (Ni) to assess background binding.
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Fig. S4. Circular dichroism spectra of Bag6-BAG (blue), Ubl4A-C (green), and the complex of the two (red).
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Fig. S5. TA handoff from SGTA to TRC40. (A) Nucleotide-dependent TA handoff facilitated by Bag6min complex. GST-TRC40 was captured on anti-GST resin
after incubation with SGTA-MBP/Sbh1 and Bag6min complex with or without ATP. Eluted samples were immunoblotted with anti-GST (red) and anti-MBP
antibody (green) and then were quantified by Odyssey Infrared Imaging System analysis software. The Sbh1 values were normalized based on total GST-TRC40
captured. The MBP-Sbh1 signal from the wild-type experiment was designated 1, and the rest are represented as a fraction of the wild-type value. Values are
average of four independent experiments. (B) TA handoff from SGTA to TRC40 facilitated by the Bag6min complex in the presence of ATP washed with buffers
with varying salt concentrations and analyzed as in A. Values are average of three independent experiments. (C) Average values of nucleotide-dependent TA
handoff from SGTA to TRC40 facilitated by the Bag6min complex. Error bars are from four independent experiments. (D) Average values of TA handoff from
SGTA to TRC40 facilitated by the Bag6min complex in the presence of ATP washed with buffers with varying salt concentrations. Error bars are from three
independent experiments. Fluorescence values are represented as a percentage of the wild-type handoff as measured by MBP fluorescence. (E) Average values
of TA handoff by binding mutants hSGTA(C38A)/MBP-Sbh1 and Bag6minUbl4A(L43A) complex compared with wild type. Error bars are from six independent
experiments. (F) Average values of TA handoff of regulatory mutants GST-TRC40(K86D) and Bag6minTRC35(D84K) complex compared with wild type. Error bars
are from four independent experiments.
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Fig. S6. The Bag6 complex is a scaffold for a broad range of activities. (A) A model of the Bag6 complex and its defined interactions. For Bag6, the locations of
the UBL (PDB ID codes 4EEW, 4DWF, and 1WX9), proline-rich domains (PR), domain of unknown function (DUF) (1), NLS (2), and the BAG domain (cyan) are
shown. Arrows indicate the five fragments of Bag6 (A, B, C, D, E) used in this study. Regions required for interaction with RP non-ATPase 10c (Rpn10c) (3), BORIS
(4), PXT1 (5), and NKp30 (6) are indicated by black lines. The regions required for binding of hydrophobic substrates and polyubiquitinated defective ribosomal
products (DRiPs) (7) are displayed in orange. The region required for Bag6 dimerization (1) is indicated on top. Proteins with defined interactions are shown as
colored boxes. Bag6-UBL–binding proteins are highlighted in yellow. The membrane-embedded ubiquitin regulatory X domain-containing protein 8 (UbxD8)
and transmembrane protein gp78 (1) are thought to anchor the Bag6 complex to the ER. Rpn10c is a component of the proteasome. For the Bag6 complex,
TRC35 (red and gray) and Ubl4A (magenta) are shown with their domains indicated. (B) Amino acid sequence of the Bag6 isoform used in this study.
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Table S1. Crystallographic analysis
Native Iodide
Data collection
Beamline ALS 8.2.1 ALS 8.2.1
Space group P21 P21
Cell dimensions
a, b, c, Å 47.2, 56.4, 75.5 47.4, 57.2, 75.9
α, β, γ, ° 90.0, 96.2, 90.0 90.0, 95.9, 90.0
Wavelength 1.0000 1.7000
Resolution, Å 19.65–2.00 (2.07–2.00) 28.6–2.70 (2.80–2.70)
Rmerge, %* 4.68 (74.85) 14.2 (162.6)
< I >/< σI >* 15.38 (1.89) 24.8 (3.0)
Completeness, %* 98.48 (97.81) 99.9 (100.0)
No. of observations 78,009 (7,708) 258,426 (26,352)
No. of unique reflections* 26,486 (2,592) 11,261 (1,127)
Multiplicity 2.9 (3.0) 22.9 (23.3)
Refinement
No. of reflections 25,149
No. of reflections test set 1,334
Rwork (%)/Rfree (%) 22.45 (33.11)/26.88 (40.64)
No. atoms (nonhydrogen) 3,296
Protein 3,167
Water 129
Average B-factor 54.60
RMSD
Bond lengths, Å 0.007
Bond angles, ° 1.07
Ramachandran plot
Favored, % 97.9
Additionally allowed, % 1.8
Outliers, % 0.3
*Highest-resolution shell is shown in parentheses.
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